{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:44:56Z","timestamp":1786981496604,"version":"build-2736575974"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["408517\/2016-6"],"award-info":[{"award-number":["408517\/2016-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["466805\/2014-4"],"award-info":[{"award-number":["466805\/2014-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11011-020-00667-3","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T02:03:06Z","timestamp":1611021786000},"page":"639-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Cannabidiol induces antidepressant and anxiolytic\u2010like effects in experimental type-1 diabetic animals by multiple sites of action"],"prefix":"10.1007","volume":"36","author":[{"given":"Yane Costa","family":"Chaves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Genaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alexandre","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joice Maria","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana\u00edna Menezes","family":"Zanoveli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"667_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.brainresbull.2018.02.002","volume":"139","author":"OM Abdelwahed","year":"2018","unstructured":"Abdelwahed OM, Tork OM, Gamal El Din MM et al (2018) Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain visfatin. Brain Res Bull 139:67\u201380","journal-title":"Brain Res Bull"},{"key":"667_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.morpho.2019.04.003","volume":"103","author":"DO Adeyemi","year":"2019","unstructured":"Adeyemi DO, Adewole OS (2019) Hibiscus sabdariffa renews pancreatic \u03b2-cells in experimental type 1 diabetic model rats. Morphologie 103:80\u201393","journal-title":"Morphologie"},{"key":"667_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/0091217417749795","volume":"53","author":"A Aftab","year":"2018","unstructured":"Aftab A, Bhat C, Gunzler D et al (2018) Associations among comorbid anxiety, psychiatric symptomatology, and diabetic control in a population with serious mental illness and diabetes: findings from an interventional randomized controlled trial. Int J Psychiatry Med 53:126\u2013140","journal-title":"Int J Psychiatry Med"},{"key":"667_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejmech.2016.02.032","volume":"113","author":"M Aghazadeh Tabrizi","year":"2016","unstructured":"Aghazadeh Tabrizi M, Baraldi PG, Ruggiero E et al (2016) Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists. Eur J Med Chem 113:11\u201327","journal-title":"Eur J Med Chem"},{"key":"667_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","volume":"24","author":"RJ Anderson","year":"2001","unstructured":"Anderson RJ, Freedland KE, Clouse RE et al (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069\u20131078","journal-title":"Diabetes Care"},{"issue":"1\u20133","key":"667_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejphar.2013.02.034","volume":"706","author":"RL Anderson","year":"2013","unstructured":"Anderson RL, Randall MD, Chan SL (2013) The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans. Eur J Pharmacol 706(1\u20133):56\u201362","journal-title":"Eur J Pharmacol"},{"key":"667_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.pharep.2016.12.004","volume":"69","author":"U Aswar","year":"2017","unstructured":"Aswar U, Chepurwar S, Shintre S et al (2017) Telmisartan attenuates diabetes induced depression in rats. Pharmacol Rep 69:358\u2013364","journal-title":"Pharmacol Rep"},{"issue":"14","key":"667_CR8","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2174\/138161209788168029","volume":"15","author":"FR Bambico","year":"2009","unstructured":"Bambico FR, Duranti A, Tontini A et al (2009) Endocannabinoids in the treatment of mood disorders: evidence from animal models. Curr Pharm Des 15(14):1623\u20131646","journal-title":"Curr Pharm Des"},{"issue":"8","key":"667_CR9","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.acthis.2014.10.001","volume":"116","author":"RH Basha","year":"2014","unstructured":"Basha RH, Sankaranarayanan C (2014) \u03b2-Caryophyllene, a natural sesquiterpene, modulates carbohydrate metabolism in streptozotocin-induced diabetic rats. Acta Histochem 116(8):1469\u20131479","journal-title":"Acta Histochem"},{"key":"667_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cbi.2015.12.019","volume":"245","author":"RH Basha","year":"2016","unstructured":"Basha RH, Sankaranarayanan C (2016) \u03b2-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats. Chem Biol Interact 245:50\u201358","journal-title":"Chem Biol Interact"},{"issue":"1\u20133","key":"667_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejphar.2007.02.066","volume":"565","author":"FJ Berm\u00fadez-Silva","year":"2007","unstructured":"Berm\u00fadez-Silva FJ, Sanchez-Vera I, Su\u00e1rez J et al (2007) Role of cannabinoid CB2 receptors in glucose homeostasis in rats. Eur J Pharmacol 565(1\u20133):207\u2013211","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"667_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/dmrr.2393","volume":"29","author":"S Bhattacharjee","year":"2013","unstructured":"Bhattacharjee S, Bhattacharya R, Kelley GA et al (2013) Antidepressant use and new-onset diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev 29(4):273\u2013284","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"667_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","volume":"134","author":"T Bisogno","year":"2001","unstructured":"Bisogno T, Hanus L, De Petrocellis L et al (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134(4):845\u2013852","journal-title":"Br J Pharmacol"},{"key":"667_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jpsychores.2018.01.001","volume":"106","author":"MT Boden","year":"2018","unstructured":"Boden MT (2018) Prevalence of mental disorders and related functioning and treatment engagement among people with diabetes. J Psychosom Res 106:62\u201369","journal-title":"J Psychosom Res"},{"key":"667_CR15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","volume":"51","author":"GW Booz","year":"2011","unstructured":"Booz GW (2011) Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Rad Biol Med 51:1054\u20131061","journal-title":"Free Rad Biol Med"},{"key":"667_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ecl.2013.10.001","volume":"43","author":"A Bystritsky","year":"2014","unstructured":"Bystritsky A, Danial J, Kronemyer D (2014) Interactions between diabetes and anxiety and depression: implications for treatment. Endocrinol Metab Clin North Am 43:269\u2013283","journal-title":"Endocrinol Metab Clin North Am"},{"key":"667_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","volume":"199","author":"AC Campos","year":"2008","unstructured":"Campos AC, Guimar\u00e3es FS (2008) Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology 199:223\u2013230","journal-title":"Psychopharmacology"},{"key":"667_CR18","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","volume":"367","author":"AC Campos","year":"2012","unstructured":"Campos AC, Moreira FA, Gomes FV et al (2012) Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc B 367:3364\u20133378","journal-title":"Philos Trans R Soc B"},{"key":"667_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","volume":"112","author":"AC Campos","year":"2016","unstructured":"Campos AC, Foga\u00e7a MV, Sonego AB et al (2016) Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol Res 112:119\u2013127","journal-title":"Pharmacol Res"},{"key":"667_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphar.2017.00269","volume":"8","author":"AC Campos","year":"2017","unstructured":"Campos AC, Foga\u00e7a MV, Scarante FF et al (2017) Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders. Front Pharmacol 8:269","journal-title":"Front Pharmacol"},{"issue":"35","key":"667_CR21","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.2174\/0929867321666140915141332","volume":"21","author":"F Carbone","year":"2014","unstructured":"Carbone F, Mach F, Vuilleumier N et al (2014) Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases. Curr Med Chem 21(35):4046\u20134058","journal-title":"Curr Med Chem"},{"key":"667_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00213-010-2051-0","volume":"214","author":"T Cassano","year":"2011","unstructured":"Cassano T, Gaetani S, Macheda T et al (2011) Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacology 214:465\u2013476","journal-title":"Psychopharmacology"},{"key":"667_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphar.2020.00124","volume":"11","author":"T Cassano","year":"2020","unstructured":"Cassano T, Villani R, Pace L et al (2020) From Cannabis sativa to cannabidiol: Promising therapeutic candidate for the treatment of neurodegenerative diseases. Front Pharmacol 11:124","journal-title":"Front Pharmacol"},{"issue":"1","key":"667_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/YCO.0000000000000562","volume":"33","author":"VL Chadwick","year":"2020","unstructured":"Chadwick VL, Rohleder C, Koethe D et al (2020) Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans. Curr Opin Psychiatry 33(1):20\u201342","journal-title":"Curr Opin Psychiatry"},{"key":"667_CR25","doi-asserted-by":"publisher","first-page":"135020","DOI":"10.1016\/j.neulet.2020.135020","volume":"729","author":"YC Chaves","year":"2020","unstructured":"Chaves YC, Genaro K, Stern CA et al (2020) Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes. Neurosci Lett 729:135020","journal-title":"Neurosci Lett"},{"issue":"3","key":"667_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/aps.2016.149","volume":"38","author":"DJ Chen","year":"2017","unstructured":"Chen DJ, Gao M, Gao FF et al (2017) Brain cannabinoid receptor 2: expression, function and modulation. Acta Pharmacol Sin 38(3):312\u2013316","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"667_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0269881110379283","volume":"25","author":"JA Crippa","year":"2011","unstructured":"Crippa JA, Derenusson GN, Ferrari TB et al (2011) Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminar report. J Psychopharmacol 25(1):121\u2013130","journal-title":"J Psychopharmacol"},{"key":"667_CR28","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3389\/fimmu.2018.02009","volume":"9","author":"JA Crippa","year":"2018","unstructured":"Crippa JA, Guimar\u00e3es FS, Campos AC et al (2018) Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age. Front Immunol 9:2009","journal-title":"Front Immunol"},{"issue":"10","key":"667_CR29","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1007\/s12035-015-9617-0","volume":"53","author":"IC da Silva Dias","year":"2016","unstructured":"da Silva Dias IC, Carabelli B, Ishii DK et al (2016) Indoleamine-2,3-Dioxygenase\/Kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes. Mol Neurobiol 53(10):6997\u20137009","journal-title":"Mol Neurobiol"},{"issue":"3","key":"667_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1538\/expanim.63.277","volume":"63","author":"JP Dami\u00e1n","year":"2014","unstructured":"Dami\u00e1n JP, Acosta V, da Cu\u00f1a M et al (2014) Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests. Exp Anim 63(3):277\u2013287","journal-title":"Exp Anim"},{"key":"667_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","volume":"36","author":"R Dantzer","year":"2011","unstructured":"Dantzer R, O\u2019Connor JC, Lawson MA et al (2011) Inflammation-associated depression: From serotonin to kynurenine. Psychoneuroendocrinology 36:426\u2013436","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"667_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","volume":"160","author":"D de Gregorio","year":"2019","unstructured":"de Gregorio D, McLaughlin RJ, Posa L et al (2019) Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain 160(1):136\u2013150","journal-title":"Pain"},{"key":"667_CR33","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2174\/1871527313666140612114838","volume":"13","author":"AR de Mello Schier","year":"2014","unstructured":"de Mello Schier AR, de Oliveira Ribeiro NP, Coutinho DS et al (2014) Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa. CNS Neurol. Disord Drug Targets 13:953\u2013960","journal-title":"Disord Drug Targets"},{"key":"667_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbr.2013.10.011","volume":"258","author":"H de Morais","year":"2014","unstructured":"de Morais H, Souza CP, Silva LM et al (2014) Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats. Behav Brain Res 258:52\u201364","journal-title":"Behav Brain Res"},{"key":"667_CR35","first-page":"1590","volume":"26","author":"H de Morais","year":"2016","unstructured":"de Morais H, Souza CP, Silva LM et al (2016) Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors. Eur J Pharmacol 26:1590\u20131600","journal-title":"Eur J Pharmacol"},{"key":"667_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2018.06.006","volume":"682","author":"H de Morais","year":"2018","unstructured":"de Morais H, Chaves Y, Waltrick A et al (2018) Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats. Neurosci Lett 682:62\u201368","journal-title":"Neurosci Lett"},{"key":"667_CR37","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.bbr.2018.09.008","volume":"359","author":"CP de Souza","year":"2018","unstructured":"de Souza CP, Gambeta E, Stern CAJ et al (2018) Posttraumatic stress disorder-type behaviors in streptozotocin-induced diabetic rats can be prevented by prolonged treatment with vitamin E. Behav Brain Res 359:749\u2013754","journal-title":"Behav Brain Res"},{"key":"667_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.biopha.2018.07.165","volume":"107","author":"F Delkhosh-Kasmaie","year":"2018","unstructured":"Delkhosh-Kasmaie F, Farshid AA, Tamaddonfard E et al (2018) The effects of safranal, a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations. Biomed Pharmacother 107:203\u2013211","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"667_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121(1):66\u201372","journal-title":"Psychopharmacology"},{"issue":"6","key":"667_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/epi.12631","volume":"55","author":"O Devinsky","year":"2014","unstructured":"Devinsky O, Cilio MR, Cross H et al (2014) Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 55(6):791\u2013802","journal-title":"Epilepsia"},{"issue":"12","key":"667_CR41","first-page":"896","volume":"61","author":"HS Dhavale","year":"2013","unstructured":"Dhavale HS, Panikkar V, Jadhav BS et al (2013) Depression and diabates: impact of anti-depressant medications on glycaemic control. J Assoc Physicians India 61(12):896\u2013899","journal-title":"J Assoc Physicians India"},{"key":"667_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-642-17214-4_4","volume":"203","author":"V Di Marzo","year":"2011","unstructured":"Di Marzo V, Piscitelli F, Mechoulam R (2011) Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handb Exp Pharmacol 203:75\u2013104","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"667_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12944-018-0938-7","volume":"18","author":"GT D\u00edaz-Gerevini","year":"2019","unstructured":"D\u00edaz-Gerevini GT, Da\u00edn A, Pasqualini ME et al (2019) Diabetic encephalopathy: beneficial effects of supplementation with fatty acids \u03c93 and nordihydroguaiaretic acid in a spontaneous diabetes rat model. Lipids Health Dis 18(1):43","journal-title":"Lipids Health Dis"},{"issue":"6","key":"667_CR44","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/17425255.2020.1754793","volume":"16","author":"RG dos Santos","year":"2020","unstructured":"dos Santos RG, Guimar\u00e3es FS, Crippa J et al (2020) Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials. Expert Opin Drug Metab Toxicol 16(6):517\u2013526","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"18","key":"667_CR45","doi-asserted-by":"publisher","first-page":"29668","DOI":"10.18632\/oncotarget.9408","volume":"8","author":"M Elbaz","year":"2017","unstructured":"Elbaz M, Ahirwar D, Ravi J et al (2017) Novel role of cannabinoid receptor 2 in inhibiting EGF\/EGFR and IGF-I\/IGF-IR pathways in breast cancer. Oncotarget 8(18):29668\u201329678","journal-title":"Oncotarget"},{"issue":"1","key":"667_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2353\/ajpath.2006.050500","volume":"168","author":"AB El-Remessy","year":"2006","unstructured":"El-Remessy AB, Al-Shabrawey M, Khalifa Y et al (2006) Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol 168(1):235\u2013244","journal-title":"Am J Pathol"},{"key":"667_CR47","first-page":"12","volume":"6","author":"G Esposito","year":"2011","unstructured":"Esposito G, Scuderi C, Valenza M et al (2011) Cannabidiol reduces A-Induced neuroinflammation and promotes hippocampal neurogenesis through PPARy. involvement PLoS ONE 6:12","journal-title":"involvement PLoS ONE"},{"key":"667_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.euroneuro.2013.10.012","volume":"24","author":"MV Foga\u00e7a","year":"2014","unstructured":"Foga\u00e7a MV, Reis FMCV, Campos AC et al (2014) Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. Eur Neuropsychopharmacol 24:410\u2013419","journal-title":"Eur Neuropsychopharmacol"},{"key":"667_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","volume":"135","author":"MV Foga\u00e7a","year":"2018","unstructured":"Foga\u00e7a MV, Campos AC, Coelho LD et al (2018) Neuropharmacology The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling. Neuropharmacology 135:22\u201333","journal-title":"Neuropharmacology"},{"key":"667_CR50","first-page":"1","volume":"7","author":"HR Freitas","year":"2017","unstructured":"Freitas HR, Isaac AR, Malcher-Lopes R et al (2017) Polyunsaturated fatty acids and endocannabinoids in health and disease. Nutr Neurosci 7:1\u201320","journal-title":"Nutr Neurosci"},{"key":"667_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0074-7742(09)85005-8","volume":"85","author":"S Gaetani","year":"2009","unstructured":"Gaetani S, Dipasquale P, Romano A et al (2009) The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. Int Rev Neurobiol 85:57\u201372","journal-title":"Int Rev Neurobiol"},{"key":"667_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnut.2018.00047","volume":"5","author":"J Gagnon","year":"2018","unstructured":"Gagnon J, Lussier MT, Macgibbon B et al (2018) The impact of antidepressant therapy on glycemic control in Canadian Primary Care patients with Diabetes Mellitus. Front Nutr 5:47","journal-title":"Front Nutr"},{"issue":"3","key":"667_CR53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11011-015-9770-1","volume":"31","author":"E Gambeta","year":"2015","unstructured":"Gambeta E, Souza CP, de Morais H (2015) Reestablishment of the hyperglycemia to the normal levels seems not to be essential to the anxiolytic-like effect induced by insulin. Metab Brain Dis 31(3):563\u2013571","journal-title":"Metab Brain Dis"},{"key":"667_CR54","doi-asserted-by":"publisher","first-page":"18620","DOI":"10.1073\/pnas.0509591102","volume":"102","author":"G Gobbi","year":"2005","unstructured":"Gobbi G, Bambico FR, Mangieri R et al (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci 102:18620\u201318625","journal-title":"Proc Natl Acad Sci"},{"key":"667_CR55","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","volume":"213","author":"FV Gomes","year":"2011","unstructured":"Gomes FV, Resstel LB, Guimar\u00e3es FS (2011) The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors. Psychopharmacology 213:465\u2013473","journal-title":"Psychopharmacology"},{"key":"667_CR56","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0022-3999(02)00417-8","volume":"53","author":"AB Grigsby","year":"2002","unstructured":"Grigsby AB, Anderson RJ, Freedland KE et al (2002) Prevalence of anxiety in adults with diabetes: A systematic review. J Psychosom Res 53:1053\u20131060","journal-title":"J Psychosom Res"},{"issue":"7","key":"667_CR57","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/bph.13226","volume":"173","author":"G Gruden","year":"2016","unstructured":"Gruden G, Barutta F, Kunos G et al (2016) Role of the endocannabinoid system in diabetes and diabetic complications. Br J Pharmacol 173(7):1116\u20131127","journal-title":"Br J Pharmacol"},{"key":"667_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejphar.2014.09.041","volume":"744","author":"D Gupta","year":"2014","unstructured":"Gupta D, Radhakrishnan M, Kurhe Y (2014) Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system. Eur J Pharmacol 744:59\u201366","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"667_CR59","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/jnr.24098","volume":"96","author":"X Han","year":"2018","unstructured":"Han X, Min M, Wang J et al (2018) Quantitative profiling of neurotransmitter abnormalities in brain, cerebrospinal fluid, and serum of experimental diabetic encephalopathy male rat. J Neurosci Res 96(1):138\u2013150","journal-title":"J Neurosci Res"},{"key":"667_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuropharm.2012.09.002","volume":"65","author":"M H\u00e4ring","year":"2013","unstructured":"H\u00e4ring M, Grieb M, Monory K et al (2013) Cannabinoid CB1 receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations. Neuropharmacology 65:83\u201389","journal-title":"Neuropharmacology"},{"issue":"9","key":"667_CR61","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tips.2009.06.006","volume":"30","author":"MN Hill","year":"2009","unstructured":"Hill MN, Hillard CJ, Bambico FR et al (2009) The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends Pharmacol Sci 30(9):484\u2013493","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"667_CR62","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ajpath.2011.11.003","volume":"180","author":"B Horv\u00e1th","year":"2012","unstructured":"Horv\u00e1th B, Mukhopadhyay P, Hask\u00f3 G et al (2012) The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. Am J Pathol 180(2):432\u2013442","journal-title":"Am J Pathol"},{"issue":"10","key":"667_CR63","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","volume":"30","author":"AA Izzo","year":"2009","unstructured":"Izzo AA, Borrelli F, Capasso R et al (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30(10):515\u2013527","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"667_CR64","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2337\/dc16-0650","volume":"39","author":"KA Jadoon","year":"2016","unstructured":"Jadoon KA, Ratcliffe SH, Barrett DA et al (2016) Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study. Diabetes Care 39(10):1777\u20131786","journal-title":"Diabetes Care"},{"key":"667_CR65","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.brainres.2019.03.014","volume":"1715","author":"CHA Jesus","year":"2019","unstructured":"Jesus CHA, Redivo DDB, Gasparin AT et al (2019) Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors. Brain Res 1715:159\u2013164","journal-title":"Brain Res"},{"issue":"1","key":"667_CR66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/nyas.13217","volume":"1391","author":"JJ Joseph","year":"2017","unstructured":"Joseph JJ, Golden SH (2017) Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci 1391(1):20\u201334","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"667_CR67","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","volume":"39","author":"P Juan-Pic\u00f3","year":"2006","unstructured":"Juan-Pic\u00f3 P, Fuentes E, Berm\u00fadez-Silva FJ et al (2006) Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. Cell Calcium 39(2):155\u2013162","journal-title":"Cell Calcium"},{"issue":"1","key":"667_CR68","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00125-016-4123-0","volume":"60","author":"H Kampling","year":"2017","unstructured":"Kampling H, Petrak F, Farin E et al (2017) Trajectories of depression in adults with newly diagnosed type 1 diabetes: results from the German Multicenter Diabetes Cohort Study. Diabetologia 60(1):60\u201368","journal-title":"Diabetologia"},{"key":"667_CR69","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fncel.2016.00294","volume":"10","author":"DA Kendall","year":"2017","unstructured":"Kendall DA, Yudowski GA (2017) Cannabinoid receptors in the central nervous system: their signaling and roles in disease. Front Cell Neurosci 10:294","journal-title":"Front Cell Neurosci"},{"key":"667_CR70","doi-asserted-by":"publisher","first-page":"172628","DOI":"10.1016\/j.ejphar.2019.172628","volume":"862","author":"VS Kumawat","year":"2019","unstructured":"Kumawat VS, Kaur G (2019) Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications. Eur J Pharmacol 862:172628","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"667_CR71","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/YCO.0000000000000527","volume":"32","author":"M Latas","year":"2019","unstructured":"Latas M, Vu\u010dini\u0107 Latas D, Spasi\u0107 Stojakovi\u0107 M (2019) Anxiety disorders and medical illness comorbidity and treatment implications. Curr Opin Psychiatry 32(5):429\u2013434","journal-title":"Curr Opin Psychiatry"},{"issue":"4","key":"667_CR72","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3233\/CH-168021","volume":"64","author":"C Lehmann","year":"2016","unstructured":"Lehmann C, Fisher NB, Tugwell B et al (2016) Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes. Clin Hemorheol Microcirc 64(4):655\u2013662","journal-title":"Clin Hemorheol Microcirc"},{"issue":"3","key":"667_CR73","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","volume":"2","author":"FM Leweke","year":"2012","unstructured":"Leweke FM, Piomelli D, Pahlisch F et al (2012) Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry 2(3):e94","journal-title":"Transl Psychiatry"},{"issue":"2","key":"667_CR74","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000320527","volume":"26","author":"C Li","year":"2010","unstructured":"Li C, Jones PM, Persaud SJ (2010) Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells. Cell Physiol Biochem 26(2):187\u2013196","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"667_CR75","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1463-1326.2011.01422.x","volume":"13","author":"C Li","year":"2011","unstructured":"Li C, Bowe JE, Huang GC et al (2011) Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans. Diabetes Obed Metab 13(10):903\u2013910","journal-title":"Diabetes Obed Metab"},{"issue":"6","key":"667_CR76","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jpsychores.2008.06.007","volume":"65","author":"EHB Lin","year":"2008","unstructured":"Lin EHB, Von Korff M, Alonso J et al (2008) Mental disorders among persons with diabetes \u2013 Results from the World Mental Health Surveys. J Psychosom Res 65(6):571\u2013580","journal-title":"J Psychosom Res"},{"key":"667_CR77","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","volume":"103","author":"R Linge","year":"2016","unstructured":"Linge R, Jim\u00e9nez-S\u00e1nchez L, Campa L et al (2016) Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors. Neuropharmacology 103:16\u201326","journal-title":"Neuropharmacology"},{"key":"667_CR78","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/diacare.15.11.1631","volume":"15","author":"PJ Lustman","year":"1992","unstructured":"Lustman PJ, Griffith LS, Gavard JA et al (1992) Depression in adults with diabetes. Diabetes Care 15:1631\u20131639","journal-title":"Diabetes Care"},{"issue":"12","key":"667_CR79","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn4036","volume":"16","author":"B Lutz","year":"2015","unstructured":"Lutz B, Marsicano G, Maldonado R et al (2015) The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neuroscience 16(12):705\u2013718","journal-title":"Nat Rev Neuroscience"},{"issue":"1","key":"667_CR80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1590\/1806-9282.60.01.013","volume":"60","author":"ACO Maia","year":"2014","unstructured":"Maia ACO, Braga AA, Paes A et al (2014) Psychiatric comorbidity in diabetes type 1: a cross-sectional observational study. Ver Assoc Med Bras 60(1):59\u201362","journal-title":"Ver Assoc Med Bras"},{"key":"667_CR81","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1124\/mol.106.029769","volume":"71","author":"JC Martel","year":"2007","unstructured":"Martel JC, Ormi\u00e8re AM, Leduc N et al (2007) Native Rat Hippocampal 5-HT1A Receptors Show Constitutive Activity. Mol Pharmacol 71:638\u2013643","journal-title":"Mol Pharmacol"},{"issue":"1","key":"667_CR82","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16(1):22\u201334","journal-title":"Nat Rev Immunol"},{"key":"667_CR83","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S2213-8587(15)00134-5","volume":"3","author":"CD Moulton","year":"2015","unstructured":"Moulton CD, Pickup JC, Ismail K (2015) The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol 3:461\u2013471","journal-title":"Lancet Diabetes Endocrinol"},{"key":"667_CR84","doi-asserted-by":"publisher","first-page":"102158","DOI":"10.1155\/2014\/102158","volume":"2014","author":"M Muriach","year":"2014","unstructured":"Muriach M, Flores-Bellver M, Romero FJ et al (2014) Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev 2014:102158","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"667_CR85","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3390\/ijms20092109","volume":"20","author":"A Nagappan","year":"2019","unstructured":"Nagappan A, Shin J, Jung MH (2019) Role of cannabinoid receptor type 1 in insulin resistance and its biological implications. Int J Mol Sci 20(9):2109","journal-title":"Int J Mol Sci"},{"key":"667_CR86","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fnins.2016.00406","volume":"10","author":"G Navarro","year":"2016","unstructured":"Navarro G, Morales P, Rodr\u00edguez-Cueto C et al (2016) Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders. Front Neurosci 10:406","journal-title":"Front Neurosci"},{"key":"667_CR87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.brainres.2016.05.013","volume":"1644","author":"WH Oliveira","year":"2016","unstructured":"Oliveira WH, Nunes AK, Fran\u00e7a ME et al (2016) Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice. Brain Res 1644:149\u2013160","journal-title":"Brain Res"},{"issue":"Pt A","key":"667_CR88","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","volume":"76","author":"S Patel","year":"2017","unstructured":"Patel S, Hill MN, Cheer JF et al (2017) The endocannabinoid system as a target for novel anxiolytic drugs. Neurosci Biobehav Rev 76(Pt A):56\u201366","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"667_CR89","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11011-018-0264-9","volume":"33","author":"MM Pereira","year":"2018","unstructured":"Pereira MM, de Morais H, dos Santos Silva E et al (2018) The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes. Metab Brain Dis 33(5):1573\u20131584","journal-title":"Metab Brain Dis"},{"issue":"2\u20133","key":"667_CR90","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","volume":"57","author":"RD Porsolt","year":"1979","unstructured":"Porsolt RD, Bertin A, Blavet N et al (1979) Immobility induced by forced swimming in rats: effects of agents wich modify central catecholamine and serotonin activity. Eur J Pharmacol 57(2\u20133):201\u2013210","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"667_CR91","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00125-016-4154-6","volume":"60","author":"F Pouwer","year":"2017","unstructured":"Pouwer F (2017) Depression: a common and burdensome complication of diabetes that warrants the continued attention of clinicians, researchers and healthcare policy makers. Diabetologia 60(1):30\u201334","journal-title":"Diabetologia"},{"issue":"1","key":"667_CR92","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0253-7613.150305","volume":"47","author":"V Prabhkar","year":"2015","unstructured":"Prabhkar V, Gupta D, Kanade P et al (2015) Diabates-associated depression: The serotonergic system as a novel multifunctional target. Indian J Pharmacol 47(1):4\u201310","journal-title":"Indian J Pharmacol"},{"issue":"5","key":"667_CR93","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","volume":"1863","author":"S Pugazhenthi","year":"2017","unstructured":"Pugazhenthi S, Qin L, Reddy PH (2017) Common neurodegenerative pathways in obesity, diabetes, and Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1863(5):1037\u20131045","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"667_CR94","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2015.10.058","volume":"298","author":"DD Redivo","year":"2016","unstructured":"Redivo DD, Schreiber AK, Adami ER et al (2016) Effect of \u00f4mega-3 polyunsaturated fatty acid treatment over mechanical allodynia and depressive-like behavior associated with experimental diabetes. Behav Brain Res 298:57\u201364","journal-title":"Behav Brain Res"},{"key":"667_CR95","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1601-5215.2011.00579.x","volume":"23","author":"GZ R\u00e9us","year":"2011","unstructured":"R\u00e9us GZ, Stringari RB, Ribeiro KF et al (2011) Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala. Acta Neuropsychiatric 23:241\u2013248","journal-title":"Acta Neuropsychiatric"},{"key":"667_CR96","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lfs.2017.06.025","volume":"183","author":"GZ R\u00e9us","year":"2017","unstructured":"R\u00e9us GZ, Augusta M, Santos B et al (2017) Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder. Life Sci 183:78\u201382","journal-title":"Life Sci"},{"key":"667_CR97","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00213-019-05388-9","volume":"237","author":"TO Ribeiro","year":"2020","unstructured":"Ribeiro TO, Bueno-De-Camargo LM, Waltrick APF et al (2020) Activation of mineralocorticoid receptors facilitate the acquisition of fear memory extinction and impair the generalization of fear memory in diabetic animals. Psychopharmacol 237:529\u2013542","journal-title":"Psychopharmacol"},{"key":"667_CR98","doi-asserted-by":"publisher","first-page":"2620e2634","DOI":"10.1111\/j.1476-5381.2011.01621.x","volume":"165","author":"EM Rock","year":"2012","unstructured":"Rock EM, Bolognini D, Limebeer CL et al (2012) Cannabidiol, a nonpsychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol 165:2620e2634","journal-title":"Br J Pharmacol"},{"issue":"3","key":"667_CR99","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s12035-018-1195-5","volume":"56","author":"S Rom","year":"2019","unstructured":"Rom S, Zuluaga-Ramirez V, Gajghate S et al (2019) Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both Diabetes Mellitus (DM) Type 1 and Type 2 mouse models. Mol Neurobiol 56(3):1883\u20131896","journal-title":"Mol Neurobiol"},{"key":"667_CR100","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0165-0327(12)70004-6","volume":"142S1","author":"T Roy","year":"2012","unstructured":"Roy T, Lloyd CE (2012) Epidemiology of depression and diabetes: A systematic review. J Affective Disord 142S1:S8\u2013S21","journal-title":"J Affective Disord"},{"issue":"8","key":"667_CR101","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","volume":"30","author":"EB Russo","year":"2005","unstructured":"Russo EB, Burnett A, Hall B et al (2005) Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30(8):1037\u20131043","journal-title":"Neurochem Res"},{"key":"667_CR102","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pnpbp.2018.06.002","volume":"86","author":"AJ Sales","year":"2018","unstructured":"Sales AJ, Crestani CC, Guimar\u00e3es FS et al (2018) Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels. Prog Neuropsychopharmacol Biol Psychiatry 86:255\u2013261","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"667_CR103","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","volume":"56","author":"AJ Sales","year":"2019","unstructured":"Sales AJ, Foga\u00e7a MV, Sartim AG et al (2019) Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex. Mol Neurobiol 56(2):1070\u20131081","journal-title":"Mol Neurobiol"},{"issue":"1","key":"667_CR104","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1758-5996-5-55","volume":"5","author":"FRM Santos","year":"2013","unstructured":"Santos FRM, Bernardo V, Gabbay MAL et al (2013) The impact of knowledge about diabetes, resilience and depression on glycemic control: A cross-sectional study among adolescents and young adults with type 1 diabetes. Diabetol Metab Syndr 5(1):55","journal-title":"Diabetol Metab Syndr"},{"key":"667_CR105","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbr.2016.01.033","volume":"303","author":"AG Sartim","year":"2016","unstructured":"Sartim AG, Guimar\u00e3es FS, Joca SR (2016) Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex - possible involvement of 5-HT1A and CB1 receptors. Behav Brain Res 303:218\u2013227","journal-title":"Behav Brain Res"},{"key":"667_CR106","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","volume":"64","author":"AP Schiavon","year":"2016","unstructured":"Schiavon AP, Bonato JM, Milani H et al (2016) Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice. Prog Neuropsychopharmacol Biol Psychiatry 64:27\u201334","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"667_CR107","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1080\/00207454.2016.1257992","volume":"127","author":"Y Shang","year":"2017","unstructured":"Shang Y, Tang Y (2017) The central cannabinoid receptor type-2 (CB2) and chronic pain. Int J Neurosci 127(9):812\u2013823","journal-title":"Int J Neurosci"},{"key":"667_CR108","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jchemneu.2019.04.006","volume":"98","author":"GP Silote","year":"2019","unstructured":"Silote GP, Sartim A, Sales A et al (2019) Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms. J Chem Neuroanat 98:104\u2013116","journal-title":"J Chem Neuroanat"},{"key":"667_CR109","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/dme.13606","volume":"35","author":"KJ Smith","year":"2018","unstructured":"Smith KJ, Desch\u00eanes SS, Schmitz N (2018) Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta-analysis. Diabet Med 35:677\u2013693","journal-title":"Diabet Med"},{"issue":"2","key":"667_CR110","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1476-5381.2012.02042.x","volume":"167","author":"S Steffens","year":"2012","unstructured":"Steffens S, Pacher P (2012) Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies. Br J Pharmacol 167(2):313\u2013323","journal-title":"Br J Pharmacol"},{"issue":"4","key":"667_CR111","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bbrc.2013.11.136","volume":"444","author":"W Suijun","year":"2014","unstructured":"Suijun W, Zhen Y, Ying G et al (2014) A role for trans-caryophyllene in the moderation of insulin secretion. Biochem Biophys Res Commun 444(4):451\u2013454","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"667_CR112","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","volume":"73","author":"C Turcotte","year":"2016","unstructured":"Turcotte C, Blanchet MR, Laviolette M et al (2016) The CB2 receptor and its role as a regulator of inflammation. Cell Mol Life Sci 73(23):4449\u20134470","journal-title":"Cell Mol Life Sci"},{"key":"667_CR113","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbacli.2016.03.009","volume":"5","author":"A Vilches-Flores","year":"2016","unstructured":"Vilches-Flores A, Franklin Z, Hauge-Evans AC et al (2016) Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction. BBA Clinical 5:143\u2013150","journal-title":"BBA Clinical"},{"key":"667_CR114","doi-asserted-by":"publisher","first-page":"1109 \u00b1 1111","DOI":"10.1248\/bpb.19.1109","volume":"19","author":"K Watanabe","year":"1996","unstructured":"Watanabe K, Kayano Y, Matsunaga T et al (1996) Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids. Biol Pharm Bull 19:1109 \u00b1 1111","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"667_CR115","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08916930500356674","volume":"39","author":"L Weiss","year":"2006","unstructured":"Weiss L, Zeira M, Reich S et al (2006) Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity 39(2):143\u2013151","journal-title":"Autoimmunity"},{"issue":"5","key":"667_CR116","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115(5):1111\u20131119","journal-title":"J Clin Invest"},{"key":"667_CR117","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s10495-019-01566-4","volume":"24","author":"M Wu","year":"2019","unstructured":"Wu M, Chen W, Zhang S et al (2019) Rotenone protects against \u03b2-cell apoptosis and attenuates type 1 diabetes mellitus. Apoptosis 24:879\u2013891","journal-title":"Apoptosis"},{"issue":"3","key":"667_CR118","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4239\/wjd.v10.i3.169","volume":"10","author":"E Xourgia","year":"2019","unstructured":"Xourgia E, Papazafiropoulou A, Melidonis A (2019) Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron. World J Diabetes 10(3):169\u2013180","journal-title":"World J Diabetes"},{"key":"667_CR119","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","volume":"159","author":"TV Zanelati","year":"2010","unstructured":"Zanelati TV, Biojone C, Moreira FA et al (2010) Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT 1A receptors. Br J Pharmacol 159:122\u2013128","journal-title":"Br J Pharmacol"},{"key":"667_CR120","first-page":"11","volume":"11","author":"JM Zanoveli","year":"2015","unstructured":"Zanoveli JM, de Morais H, da Silva ICD et al (2015) Depression associated with diabetes: from pathophysiology to treatment. Curr Diabetes Rev 11:11\u201314","journal-title":"Curr Diabetes Rev"},{"issue":"8","key":"667_CR121","first-page":"435","volume":"72","author":"D Zhou","year":"2017","unstructured":"Zhou D, Li Y, Tian T et al (2017) Role of the endocannabinoid system in the formation and development of depression. Pharmazie 72(8):435\u2013439","journal-title":"Pharmazie"},{"key":"667_CR122","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fphar.2017.00259","volume":"8","author":"AW Zuardi","year":"2017","unstructured":"Zuardi AW, Rodrigues NP, Silva AL et al (2017) Inverted u-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life. Front Pharmacol 8:259","journal-title":"Front Pharmacol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00667-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-020-00667-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00667-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T04:05:40Z","timestamp":1674878740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-020-00667-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1007\/s11011-020-00667-3","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"3 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JAC is co-inventor (Mechoulam R, JC, Guimaraes FS, AZ, JH, Breuer A) of the patent \u201cFluorinated CBD compounds, compositions and uses thereof. Pub. No.: WO\/2014\/108899. International Application No.: PCT\/IL2014\/050023\u201d Def. US no. Reg. 62,193,296; 29\/07\/2015; INPI on 19\/08\/2015 (BR1120150164927). The University of S\u00e3o Paulo has licensed the patent to Phytecs Pharm (USP Resolution No. 15.1.130002.1.1). The University of S\u00e3o Paulo has an agreement with Prati-Donaduzzi (Toledo, Brazil) to \u201cdevelop a pharmaceutical product containing synthetic cannabidiol and prove its safety and therapeutic efficacy in the treatment of epilepsy, schizophrenia, Parkinson\u2019s disease, and anxiety disorders.\u201d JAC has received travel support from and was medical advisor of SCBD Centre. JAC has received a grant from University Global Partnership Network (UGPN) \u2013 \u201cGlobal priorities in cannabinoid research excellence.\u201d JAC is member of the international advisory board of The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), funded by the National Health and Medical Research Council through the Centre of Research Excellence).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of conflicting interests"}},{"value":"All experiments were conducted in accordance with the rules and legislation contained by the UFPR Animal Research Ethics Committee (CEUA number #1106).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}